Collaborations Pharmaceuticals
Business Services · North Carolina, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
840 Main Campus Dr Ste 3510 # Lab, Ralei...Phone Number
(919) 515-5941Website
www.collaborationspharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About Collaborations Pharmaceuticals
Collaborations Pharmaceuticals, Inc.® (CPI) performs research and development on innovative therapeutics and has a preclinical pipeline of treatments for rare and neglected diseases. In addition, CPI has developed software for data curation and machine learning called Assay Central® (www.assaycentral.org) as well as curated model bundles in MegaTox®, MegaTrans® and MegaPredict®. Most recently the company has developed generative software called MegaSyn and UV-adVISor for predicting UV-Vis spectra for small molecules. CPI is located in laboratories in the NC State Incubator at the Centennial campus. The company has considerable experience with preclinical and computational approaches to drug discovery and toxicity prediction.Explore more
Popular SearchesCollaborations Pharmaceuticals IncCollaborations PharmaceuticalsSIC Code 87,873NAICS Code 54,541Show moreCollaborations Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Collaborations Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Collaborations Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Collaborations Pharmaceuticals has new funding data
Check if Collaborations Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Collaborations Pharmaceuticals launches new products
Click to see if Collaborations Pharmaceuticals had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Check out if Collaborations Pharmaceuticals is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Collaborations Pharmaceuticals
Earning: See what the market has to say on Collaborations Pharmaceuticals recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Collaborations Pharmaceuticals
Find 2 more new buyers
Compare Similar Companies to Collaborations Pharmaceuticals
Compare insights from companies similar to Collaborations Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Collaborations Pharmaceuticals is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Collaborations Pharmaceuticals is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Collaborations Pharmaceuticals.
Collaborations Pharmaceuticals financials insights
Gather financial insights about Collaborations Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Debt
$104K
Collaborations Pharmaceuticals Tech Stack
A closer look at the technologies used by Collaborations Pharmaceuticals
Most Recent Scoops
Funding
Project
Spending/Investment, Funding
Event
Product Marketing, Events, Sales, Food & Beverage, Hospitality, Field /Outside Sales, Field Marketing
Event
Events
Funding
Collaborations Pharmaceuticals News & Media
Collaborations Pharmaceuticals, Inc., Invited to Participate in the Reckitt “The Science Inside Symposium 2024”
Collaborations Pharmaceuticals, Inc., are pleased to announce their invitation from Reckitt to participate in The Science Inside Symposium 2024 RALEIGH, NC, USA, July 8, 2024 /EINPresswire.com/ -- Collaborations Pharmaceuticals, Inc., are pleased to …Collaborations Pharmaceuticals, Inc., Opens New Raleigh Office
Collaborations Pharmaceuticals, Inc., announce the opening of a new office in Raleigh, NC, to house their software development, business and operations teams. RALEIGH, NC, USA, May 17, 2024 /EINPresswire.com/ -- Collaborations Pharmaceuticals, Inc. (CPI …Collaborations Pharmaceuticals, Inc. Introduce Batten Disease CLN1 Registry In Order to Find Patients
Collaborations Pharmaceuticals, Inc. has developed a registry for Batten Disease CLN1 In order to find patients with this rare disease and gather information. RALEIGH, NC, USA, April 11, 2024 /EINPresswire.com/ -- “We are proud to announce the release …Collaboration Leads to Repurposing an Existing Drug to Treat VX Poisoning
Collaborations Pharmaceuticals and Battelle published a new paper which demonstrated that an FDA approved drug may help in VX poisoning. RALEIGH, NORTH CAROLINA, USA, April 11, 2024 /EINPresswire.com/ -- VX is an organophosphate acetylcholinesterase ( …
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Collaborations Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Collaborations Pharmaceuticals, Inc.® (CPI) performs research and development on innovative therapeutics and has a preclinical pipeline of treatments for rare and neglected diseases. In addition, CPI has developed software for data curation and machine learning called Assay Central® (www.assaycentral.org) as well as curated model bundles in MegaTox... Read More
